Literature DB >> 26621847

Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling.

Jacob J Kennedy1, Ping Yan1, Lei Zhao1, Richard G Ivey1, Uliana J Voytovich1, Heather D Moore1, Chenwei Lin1, Era L Pogosova-Agadjanyan1, Derek L Stirewalt1, Kerryn W Reding2, Jeffrey R Whiteaker1, Amanda G Paulovich3.   

Abstract

A major goal in cell signaling research is the quantification of phosphorylation pharmacodynamics following perturbations. Traditional methods of studying cellular phospho-signaling measure one analyte at a time with poor standardization, rendering them inadequate for interrogating network biology and contributing to the irreproducibility of preclinical research. In this study, we test the feasibility of circumventing these issues by coupling immobilized metal affinity chromatography (IMAC)-based enrichment of phosphopeptides with targeted, multiple reaction monitoring (MRM) mass spectrometry to achieve precise, specific, standardized, multiplex quantification of phospho-signaling responses. A multiplex immobilized metal affinity chromatography- multiple reaction monitoring assay targeting phospho-analytes responsive to DNA damage was configured, analytically characterized, and deployed to generate phospho-pharmacodynamic curves from primary and immortalized human cells experiencing genotoxic stress. The multiplexed assays demonstrated linear ranges of ≥3 orders of magnitude, median lower limit of quantification of 0.64 fmol on column, median intra-assay variability of 9.3%, median inter-assay variability of 12.7%, and median total CV of 16.0%. The multiplex immobilized metal affinity chromatography- multiple reaction monitoring assay enabled robust quantification of 107 DNA damage-responsive phosphosites from human cells following DNA damage. The assays have been made publicly available as a resource to the community. The approach is generally applicable, enabling wide interrogation of signaling networks.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26621847      PMCID: PMC4739685          DOI: 10.1074/mcp.O115.054940

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  62 in total

1.  PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.

Authors:  Matthew P Stokes; Charles L Farnsworth; Albrecht Moritz; Jeffrey C Silva; Xiaoying Jia; Kimberly A Lee; Ailan Guo; Roberto D Polakiewicz; Michael J Comb
Journal:  Mol Cell Proteomics       Date:  2012-02-09       Impact factor: 5.911

2.  Autophosphorylation and ATM activation: additional sites add to the complexity.

Authors:  Sergei V Kozlov; Mark E Graham; Burkhard Jakob; Frank Tobias; Amanda W Kijas; Marcel Tanuji; Philip Chen; Phillip J Robinson; Gisela Taucher-Scholz; Keiji Suzuki; Sairai So; David Chen; Martin F Lavin
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

3.  Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays.

Authors:  A Prakash; T Rezai; B Krastins; D Sarracino; M Athanas; P Russo; M M Ross; H Zhang; Y Tian; V Kulasingam; A P Drabovich; C Smith; I Batruch; L Liotta; E Petricoin; E P Diamandis; D W Chan; M F Lopez
Journal:  J Proteome Res       Date:  2010-11-02       Impact factor: 4.466

4.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Authors:  Terri A Addona; Susan E Abbatiello; Birgit Schilling; Steven J Skates; D R Mani; David M Bunk; Clifford H Spiegelman; Lisa J Zimmerman; Amy-Joan L Ham; Hasmik Keshishian; Steven C Hall; Simon Allen; Ronald K Blackman; Christoph H Borchers; Charles Buck; Helene L Cardasis; Michael P Cusack; Nathan G Dodder; Bradford W Gibson; Jason M Held; Tara Hiltke; Angela Jackson; Eric B Johansen; Christopher R Kinsinger; Jing Li; Mehdi Mesri; Thomas A Neubert; Richard K Niles; Trenton C Pulsipher; David Ransohoff; Henry Rodriguez; Paul A Rudnick; Derek Smith; David L Tabb; Tony J Tegeler; Asokan M Variyath; Lorenzo J Vega-Montoto; Asa Wahlander; Sofia Waldemarson; Mu Wang; Jeffrey R Whiteaker; Lei Zhao; N Leigh Anderson; Susan J Fisher; Daniel C Liebler; Amanda G Paulovich; Fred E Regnier; Paul Tempst; Steven A Carr
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

5.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

Authors:  D Cortez; Y Wang; J Qin; S J Elledge
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

6.  A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

Authors:  Terri A Addona; Xu Shi; Hasmik Keshishian; D R Mani; Michael Burgess; Michael A Gillette; Karl R Clauser; Dongxiao Shen; Gregory D Lewis; Laurie A Farrell; Michael A Fifer; Marc S Sabatine; Robert E Gerszten; Steven A Carr
Journal:  Nat Biotechnol       Date:  2011-06-19       Impact factor: 54.908

7.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

8.  GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy.

Authors:  Yu Xue; Jian Ren; Xinjiao Gao; Changjiang Jin; Longping Wen; Xuebiao Yao
Journal:  Mol Cell Proteomics       Date:  2008-05-06       Impact factor: 5.911

9.  Improved enrichment strategies for phosphorylated peptides on titanium dioxide using methyl esterification and pH gradient elution.

Authors:  Eric S Simon; Matthew Young; Antonia Chan; Zhao-Qin Bao; Philip C Andrews
Journal:  Anal Biochem       Date:  2008-03-22       Impact factor: 3.365

10.  Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.

Authors:  Steven A Carr; Susan E Abbatiello; Bradley L Ackermann; Christoph Borchers; Bruno Domon; Eric W Deutsch; Russell P Grant; Andrew N Hoofnagle; Ruth Hüttenhain; John M Koomen; Daniel C Liebler; Tao Liu; Brendan MacLean; D R Mani; Elizabeth Mansfield; Hendrik Neubert; Amanda G Paulovich; Lukas Reiter; Olga Vitek; Ruedi Aebersold; Leigh Anderson; Robert Bethem; Josip Blonder; Emily Boja; Julianne Botelho; Michael Boyne; Ralph A Bradshaw; Alma L Burlingame; Daniel Chan; Hasmik Keshishian; Eric Kuhn; Christopher Kinsinger; Jerry S H Lee; Sang-Won Lee; Robert Moritz; Juan Oses-Prieto; Nader Rifai; James Ritchie; Henry Rodriguez; Pothur R Srinivas; R Reid Townsend; Jennifer Van Eyk; Gordon Whiteley; Arun Wiita; Susan Weintraub
Journal:  Mol Cell Proteomics       Date:  2014-01-17       Impact factor: 5.911

View more
  22 in total

1.  Nonlinear Regression Improves Accuracy of Characterization of Multiplexed Mass Spectrometric Assays.

Authors:  Cyril Galitzine; Jarrett D Egertson; Susan Abbatiello; Clark M Henderson; Lindsay K Pino; Michael MacCoss; Andrew N Hoofnagle; Olga Vitek
Journal:  Mol Cell Proteomics       Date:  2018-02-09       Impact factor: 5.911

Review 2.  Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease.

Authors:  Paolo Cifani; Alex Kentsis
Journal:  Proteomics       Date:  2016-12-21       Impact factor: 3.984

3.  Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma.

Authors:  Shivangi Awasthi; Tapan Maity; Benjamin L Oyler; Yue Qi; Xu Zhang; David R Goodlett; Udayan Guha
Journal:  J Proteomics       Date:  2018-04-13       Impact factor: 4.044

Review 4.  The current state of the art of quantitative phosphoproteomics and its applications to diabetes research.

Authors:  Chi Yuet X'avia Chan; Marina A Gritsenko; Richard D Smith; Wei-Jun Qian
Journal:  Expert Rev Proteomics       Date:  2016       Impact factor: 3.940

Review 5.  Clinical potential of mass spectrometry-based proteogenomics.

Authors:  Bing Zhang; Jeffrey R Whiteaker; Andrew N Hoofnagle; Geoffrey S Baird; Karin D Rodland; Amanda G Paulovich
Journal:  Nat Rev Clin Oncol       Date:  2019-04       Impact factor: 66.675

6.  Transitioning from Targeted to Comprehensive Mass Spectrometry Using Genetic Algorithms.

Authors:  Jacob D Jaffe; Caitlin M Feeney; Jinal Patel; Xiaodong Lu; D R Mani
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-25       Impact factor: 3.109

7.  Targeted Quantification of Phosphorylation Dynamics in the Context of EGFR-MAPK Pathway.

Authors:  Lian Yi; Tujin Shi; Marina A Gritsenko; Chi-Yuet X'avia Chan; Thomas L Fillmore; Becky M Hess; Adam C Swensen; Tao Liu; Richard D Smith; H Steven Wiley; Wei-Jun Qian
Journal:  Anal Chem       Date:  2018-04-03       Impact factor: 6.986

Review 8.  Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  J Proteomics       Date:  2018-02-13       Impact factor: 4.044

9.  Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Richard G Ivey; Marilyn Sanchez-Bonilla; Heather D Moore; Regine M Schoenherr; Ping Yan; Chenwei Lin; Akiko Shimamura; Amanda G Paulovich
Journal:  DNA Repair (Amst)       Date:  2018-03-21

10.  A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Rick Saul; Jan A Kaczmarczyk; Regine M Schoenherr; Heather D Moore; Corey Jones-Weinert; Richard G Ivey; Chenwei Lin; Tara Hiltke; Kerryn W Reding; Gordon Whiteley; Pei Wang; Amanda G Paulovich
Journal:  Radiat Res       Date:  2018-02-23       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.